Measles, Mumps, Rubella & Varicella Vaccine (MMRV) [Priorix-Tetra]
Availability of ACE Drug Guidance
No
Biologics Drug Information Overview
No
Subsidy Information and Financing Scheme
Subsidised Vaccine List
Active ingredients: Vaccine Measles | Measles Vaccine | Vaccine Mumps | Mumps Vaccine | Vaccine Rubella | Rubella Vaccine | Vaccine Varicella | Varicella Vaccine | Measles, Mumps, Rubella & Varicella Vaccine (MMRV)
General information
Subsidy Information and Financing Scheme
[SVL] Measles, Mumps, Rubella & Varicella Vaccine (MMRV) (Priorix-Tetra) Injection, Measles Virus Vaccine (live-attenuated) minimum 103.0 CCID50/0.5 mL + Mumps Virus Vaccine (live-attenuated) minimum 104.4 CCID50/0.5 mL + Rubella Virus Vaccine (live-attenuated) minimum 103.0 CCID50/0.5 mL + Varicella-Zoster Virus Vaccine (live, attenuated) minimum 103.3 plaque-forming units/0.5 mL
National Childhood Immunisation Schedule (NCIS)
Drug Guidance for Subsidy
Not Applicable
Registered Product(s) Information
Clinical and product info
Clinical info | Product Info |
|---|---|
Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch (opens in new tab). The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice. | Information available here are product details as registered with the HSA. As this website is updated monthly, please refer to HSA Infosearch (opens in new tab) for the most updated product information. |
Subcutaneous / Intramuscular
* Clinical information is available for this product.